Regulation of the ovarian reserve by members of the transforming growth factor beta family

被引:108
作者
Pangas, Stephanie A. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
ANTI-MULLERIAN HORMONE; BONE MORPHOGENETIC PROTEIN-15; PRIMORDIAL GERM-CELLS; RIBONUCLEIC-ACID EXPRESSION; OOCYTE-SPECIFIC DELETION; AFFECT FEMALE FERTILITY; DIFFERENTIATION FACTOR-9; KIT-LIGAND; FOLLICULAR DEVELOPMENT; II RECEPTOR;
D O I
10.1002/mrd.22076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Genetic or environmental factors that affect the endowment of oocytes, their assembly into primordial follicles, or their subsequent entry into the growing follicle pool can disrupt reproductive function and may underlie disorders such as primary ovarian insufficiency. Mouse models have been instrumental in identifying genes important in ovarian development, and a number of genes now associated with ovarian dysfunction in women were first identified as causing reproductive defects in knockout mice. The transforming growth factor beta (TGFB) family consists of developmentally important growth factors that include the TGFBs, anti-Mullerian hormone (AMH), activins, bone morphogenetic proteins (BMPs), and growth and differentiation factor 9 (GDF9). The ovarian primordial follicle pool is the source of oocytes in adults. Development of this pool can be grossly divided into three key processes: (1) establishment of oocytes during embryogenesis followed by (2) assembly and (3) activation of the primordial follicle. Disruptions in any of these processes may cause reproductive dysfunction. Most members of the TGFB family show pivotal roles in each of these areas. Understanding the phenotypes of various mouse models for this protein family will be directly relevant to understanding how disruptions in TGFB family signaling result in reproductive diseases in women and will present new areas for development of tailored diagnostics and interventions for infertility. Mol. Reprod. Dev. 79: 666679, 2012. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:666 / 679
页数:14
相关论文
共 165 条
[1]
Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles [J].
Adhikari, Deepak ;
Liu, Kui .
ENDOCRINE REVIEWS, 2009, 30 (05) :438-464
[2]
A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice [J].
Arango, Nelson A. ;
Kobayashi, Akio ;
Wang, Ying ;
Jamin, Soazik P. ;
Lee, Hu-Hui ;
Orvis, Grant D. ;
Behringer, Richard R. .
MOLECULAR REPRODUCTION AND DEVELOPMENT, 2008, 75 (07) :1154-1162
[3]
ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN RAT OVARIES DURING POSTNATAL-DEVELOPMENT, THE ESTROUS-CYCLE, AND GONADOTROPIN-INDUCED FOLLICLE GROWTH [J].
BAARENDS, WM ;
UILENBROEK, JTJ ;
KRAMER, P ;
HOOGERBRUGGE, JW ;
VANLEEUWEN, ECM ;
THEMMEN, APN ;
GROOTEGOED, JA .
ENDOCRINOLOGY, 1995, 136 (11) :4951-4962
[4]
A QUANTITATIVE AND CYTOLOGICAL STUDY OF GERM CELLS IN HUMAN OVARIES [J].
BAKER, TG .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1963, 158 (972) :417-+
[5]
Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators [J].
Balemans, W ;
Van Hul, W .
DEVELOPMENTAL BIOLOGY, 2002, 250 (02) :231-250
[6]
MULLERIAN-INHIBITING SUBSTANCE FUNCTION DURING MAMMALIAN SEXUAL DEVELOPMENT [J].
BEHRINGER, RR ;
FINEGOLD, MJ ;
CATE, RL .
CELL, 1994, 79 (03) :415-425
[7]
BLOCK E, 1952, ACTA ANAT, V14, P108
[8]
Misregulated Wnt/β-catenin signaling leads to ovarian granulosa cell tumor development [J].
Boerboom, D ;
Paquet, M ;
Hsieh, N ;
Liu, JS ;
Jamin, SP ;
Behringer, RR ;
Sirois, J ;
Taketo, MM ;
Richards, JS .
CANCER RESEARCH, 2005, 65 (20) :9206-9215
[9]
Novel NOBOX Loss-of-Function Mutations Account for 6.2% of Cases in a Large Primary Ovarian Insufficiency Cohort [J].
Bouilly, Justine ;
Bachelot, Anne ;
Broutin, Isabelle ;
Touraine, Philippe ;
Binart, Nadine .
HUMAN MUTATION, 2011, 32 (10) :1108-1113
[10]
A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse [J].
Nolan, PM ;
Peters, J ;
Strivens, M ;
Rogers, D ;
Hagan, J ;
Spurr, N ;
Gray, IC ;
Vizor, L ;
Brooker, D ;
Whitehill, E ;
Washbourne, R ;
Hough, T ;
Greenaway, S ;
Hewitt, M ;
Liu, XH ;
McCormack, S ;
Pickford, K ;
Selley, R ;
Wells, C ;
Tymowska-Lalanne, Z ;
Roby, P ;
Glenister, P ;
Thornton, C ;
Thaung, C ;
Stevenson, JA ;
Arkell, R ;
Mburu, P ;
Hardisty, R ;
Kiernan, A ;
Erven, H ;
Steel, KP ;
Voegeling, S ;
Guenet, JL ;
Nickols, C ;
Sadri, R ;
Naase, M ;
Isaacs, A ;
Davies, K ;
Browne, M ;
Fisher, EMC ;
Martin, J ;
Rastan, S ;
Brown, SDM ;
Hunter, J .
NATURE GENETICS, 2000, 25 (04) :440-443